Regulation of humoral immune responses by CD21/CD35

Immunological Reviews

Volumn 176, Issue , 2000, Pages 194-204

  Chen, Z ^a   Koralov, S B ^a   Kelsoe, G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C3D RECEPTOR; HAPTEN;

ANTIGEN PRESENTATION; B LYMPHOCYTE; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT DEPOSITION; COMPLEMENT SYSTEM; GERMINAL CENTER; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNITY; PRIORITY JOURNAL; RECEPTOR AFFINITY; REGULATORY MECHANISM; REVIEW; TRANSGENIC MOUSE;

EID: 0033822270     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2000.00603.x     Document Type: Review

References (84)

1. Receptors for complement of leukocytes
2. A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization
3. Receptors for immune complexes on lymphocytes
4. Role of complement in induction of the allergic response
5. In vivo studies in C4-deficient guinea pigs
6. Immune response of a patient with deficiency of the fourth component of complement and systemic lupus erythematosus
7. The role of complement in the induction of antibody responses
8. Impaired humoral immune response in complement C3-deficient guinea pigs: Absence of secondary antibody response
9. Guinea pigs deficient in C2, C4, C3 or the C3a receptor
10. Regulation of the B cell response to T-dependent antigens by classical pathway complement
11. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen
12. The role of complement and complement receptors in induction and regulation of immunity
13. CD21/CD35 in B cell activation
14. The CD 19/CR2/TAPA- 1 complex of B lymphocytes: Linking natural to acquired immunity
15. Molecular interactions of complement receptors on B lymphocytes: A CR1/CR2 complex distinct from the CR2/CD19 complex
16. Intersection of the complement and immune systems: A signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19
17. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules
18. The signaling activity of murine CD19 is regulated during cell development
19. The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity
20. Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes
21. 2+ mobilization of chronic lymphocytic leukemia B cells
22. Suppression of the immune response by a soluble complement receptor of B lymphocytes
23. In vivo inhibition of the antibody response by a complement receptor-specific monodonal antibody
24. Modulation of mouse complement receptors 1 and 2 suppresses antibody responses in vivo
25. Antibodies to routine complement receptor 1 and 2 can inhibit the antibody response in vivo without inhibiting T helper cell induction
26. Immunoglobulin production by human peripheral lymphocytes induced by anti-C3 receptor antibodies
27. Monoclonal antibodies to the human C3b/C4b receptor (CR1) enhance specific B cell differentiation
28. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2
29. Life and death in germinal centers (redux)
30. Germinal centers
31. Interleukin 6 influences germinal center development and antibody production via a contribution of C3 complement component
32. Expression of complement receptors 1 and 2 on follicular dendritic ceils is necessary for the generation of a strong antigen-specific IgG response
33. A subset of anti-CD21 antibodies promote the rescue of germinal center B cells from apoptosis
34. The follicular dendritic cell: Its role in antigen presentation in the generation of immunological memory
35. The follicular dendritic cell: Long term antigen retention during immunity
36. The central role of follicular dendritic cells in lymphoid tissues
37. Follicular dendritic cells and presentation of antigen and costimulatory signals to B cells
38. Co-ligation of mouse complement receptors 1 and 2 with surface IgM rescues splenic B cells and WEHI-231 cells from anti-surface IgM-induced apoptosis
39. Recruitment of the CD19/CD21 coreceptor to B cell antigen receptor is required for antigen-mediated expression of Bcl-2 by resting and cycling hen egg lysozyme transgenic B cells
40. Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the survival gene bcl-2
41. Bcl-x rather than Bcl-2 mediates CD40-dependent centrocyte survival in the germinal center
42. Relaxed negative selection in germinal centers and impaired affinity maturation in bcl-xL transgenic mice
43. Dependence of germinal center B cells on expression of CD21/CD35 for survival
44. Dual antigen recognition by B cells
45. Complement dependence of localisation of aggregated IgG in germinal centres
46. Localization of a protein antigen in the chicken spleen. Effect of various manipulative procedures on the morphogenesis of the germinal centre
47. The generation of memory cells. I. The role of C3 in the generation of B memory cells
48. Activation of mouse complement by monoclonal mouse antibodies
49. The half-lives of serum immunoglobulins in adult mice
50. Structure and function of human and murine receptors for IgG
51. Amplified follicular immune complex deposition in mice lacking the Fc receptor γ-chain does not alter maturation of the B cell response
52. Augmented humoral and anaphylactic responses in Fc γ RII-deficient mice
53. Evidence for an important interaction between a complement-derived CD21 ligand on follicular dendritic cells and CD21 on B cells in the initiation of IgG responses
54. The origin of follicular dendritic cells in the mouse and the mechanism of trapping of immune complexes on them
55. Antibody response to a T-dependent antigen requires B cell expression of complement receptors
56. CD19: Lowering the threshold for antigen receptor stimulation of B lymphocytes
57. C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity
58. The action of human C3 in soluble or cross-linked form with resting and activated murine B lymphocytes
59. Growth control of activated, synchronized murine B cells by the C3d fragment of human complement
60. Enhancement of human B cell proliferation by an antibody to the C3d receptor, the gp 140 molecule
61. Monoclonal antibodies to the 140, 000 mol wt glycoprotein of B lymphocyte membranes (CR2 receptor) initiates proliferation of B cells in vitro
62. Binding of monoclonal antibody to the Epstein Burr virus (EBV)/CR2 receptor induces activation and differentiation of human B lympkocytes
63. The role of receptors for complement in the induction of polyclonal B-cell proliferation and differentiation
64. Polymeric c3dg primes human B lymphocytes for proliferation induced by anti-IgM
65. Monovalent ligands of complement receptor 2 inhibit whereas polyvalent ligands enhance anti-Ig-induced human B cell intracytoplasmic free calcium concentration
66. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule
67. Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B-lymphocyte development
68. CD 19 expression levels regulate B lymphocyte development: Human CD 19 restores normal function in mice lacking endogenous CD 19
69. In situ studies of the germinal center reaction
70. Inherited immunoglobulin idiotypes of the mouse
71. Analysis of the repertoire of anti-NP antibodies in C57BL/6 mice by cell fusion. I. Characterization of antibody families in the primary and hyperimmune response
72. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. III. The kinetics of V region mutation and selection in germinal center B cells
73. Humoral immune responses in Cr2(-/-) mice: Enhanced affinity maturation but impaired antibody persistence
74. Bone marrow is a major site of long-term antibody production after acute viral infection
75. Lifetime of plasma cells in the bone marrow
76. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. V. Affinity maturation develops in two stages of clonal selection
77. Humoral immunity due to long-lived plasma cells
78. Antigen drives very low affinity B cells to become plasmacytes and enter germinal centers
79. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations
80. Soluble antigen can impede affinity maturation and the germinal center reaction but enhance extrafollicular immunoglobulin production
81. Antigen-induced B-cell death and elimination during germinal-centre immune responses
82. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. IV. Affinity-dependent, antigen-driven B cell apoptosis in germinal centers as a mechanism for maintaining self-tolerance
83. Role of complement in induction of antibody production in vivo. Effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses